Kinaxis Inc. Reports First Quarter 2024 Results

Kinaxis Inc. Reports First Quarter 2024 Results

 
  • Q1 SaaS revenue grows 16%, adjusted EBITDA 1 margin of 19%, annual recurring revenue grows 15%
  •  
  • Increases FY 2024 adjusted EBITDA 1 guidance as key initiative heightens focus on profitability
  •  

  Kinaxis   ® (TSX:KXS), a leading provider of supply chain orchestration solutions, reported results for its first quarter ended March 31, 2024. All amounts are in U.S. dollars. All figures are prepared in accordance with IFRS Accounting Standards unless otherwise indicated.

 

"During the first quarter, Kinaxis continued to add exciting new brands to our customer base while delivering solid financial results. We were once again named a Leader in the 2024 Gartner ® Magic Quadrant™ for Supply Chain Planning Solutions, with recognition for our strong product vision and the highest positioning on Ability to Execute," said John Sicard, president and chief executive officer at Kinaxis. "The supply chain markets continue to evolve rapidly and we are reshaping the organization to ensure we capitalize on the best opportunities ahead. With our ongoing product leadership, we are in a better position than ever to transform the world's supply chains through AI-powered end-to-end orchestration."

 

  Q1 2024 Highlights  

 
                                                     
 

$ USD thousands, except as otherwise indicated

 
  Q1 2024    Q1 2023    Change  
 

  Total Revenue  

 
 

  119,370  

 
 

101,130

 
 

18%

 
 

  SaaS  

 
 

73,371

 
 

63,145

 
 

16%

 
 

  Subscription term licenses  

 
 

6,741

 
 

7,028

 
 

(4)%

 
 

  Professional services  

 
 

34,443

 
 

26,568

 
 

30%

 
 

  Maintenance and support  

 
 

4,815

 
 

4,389

 
 

10%

 
 

  Gross profit  

 
 

  72,930  

 
 

61,001

 
 

20%

 
 

  Margin  

 
 

61%

 
 

60%

 
 

 

 
 

  Profit  

 
 

  6,187  

 
 

1,189

 
 

420%

 
 

  Per diluted share  

 
 

$0.21

 
 

$0.04

 
 

 

 
 

  Adjusted EBITDA 1  

 
 

  22,680  

 
 

17,142

 
 

32%

 
 

  Margin  

 
 

19%

 
 

17%

 
 
 

  Cash from operating activities  

 
 

  32,011  

 
 

38,905

 
 

(18)%

 
 

  (1) "Adjusted EBITDA" is a non-IFRS measure and is not a recognized, defined or standardized measure under IFRS. This measure as well as any other non-IFRS financial measures reported by Kinaxis are defined in the "Non-IFRS Measures" section of this news release.  

 
 

In the first quarter of 2024, Kinaxis initiated a restructuring of its organization to focus on its next wave of growth, eliminating approximately 6% of its workforce across functions and geographical regions. Some restructuring charges have been incurred in the first quarter of 2024, and the company expects that the majority of related charges will be incurred in the second quarter, by the end of which the initiative will be substantially complete. Kinaxis intends to reinvest a portion of savings into key product innovations and go-to-market priorities throughout the remainder of the year and into 2025.

 

  Key Performance Indicators
The company's Annual Recurring Revenue 2 (ARR), which includes subscription amounts related to both SaaS and on-premise contracts, rose 15% to $327 million at the end of the quarter.

 
            
 

  $USD millions  

 
 

  Q1 2024  

 
 

  Q1 2023  

 
 

  Change  

 
 

  Annual recurring revenue 2  

 
 

$

 
 

327

 
 

$

 
 

285

 
 

15

 
 

%

 
 

  (2) Annual Recurring Revenue (ARR) is the total annualized value of recurring subscription amounts (ultimately recognized as SaaS, Subscription term licenses and Maintenance and support revenue) of all subscription contracts at a point in time. Annualized subscription amounts are determined solely by reference to the underlying contracts, normalizing for the varying revenue recognition treatments under IFRS 15 for cloud-based versus on-premise subscription amounts. It excludes one-time fees, such as for non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that this measure provides a more current indication of our performance in the growth of our subscription business than other metrics.  

 
 

The nature of the company's long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at March 31, 2024.

 
                         
 

 

 

  $USD millions  

 
 

  Remainder of  

 

  2024  

 
 

 

 

  2025  

 
 

 

 

  2026 and later  

 
 

 

 

  Total  

 
 

  SaaS  

 
 

215.7

 
 

215.6

 
 

258.4

 
 

  689.7  

 
 

  Maintenance and support  

 
 

14.8

 
 

14.7

 
 

12.3

 
 

  41.8  

 
 

  Subscription term licenses  

 
 

2.0

 
 

0.1

 
 

 
 

  2.1  

 
 

  Total  

 
 

232.5

 
 

230.4

 
 

270.7

 
 

  733.6  

 
 

  Financial Guidance
Kinaxis is increasing its fiscal 2024 Adjusted EBITDA margin guidance, while maintaining all other elements of guidance, as follows:

 
          
 

 

 
 

  FY 2024 Guidance  

 
 

  Total revenue  

 
 

$483-495 million

 
 

  SaaS  

 
 

17-19% growth

 
 

  Subscription term license  

 
 

$9-11 million

 
 

  Adjusted EBITDA 1 margin  

 
 

18-20%

 
 

"I'm pleased to be able to increase our Adjusted EBITDA guidance for fiscal 2024, which reflects both the cost savings from our restructuring initiative and some anticipated reinvestment in the year. We have taken a major step forward in our progress towards achieving our target of consistently achieving 25% Adjusted EBITDA in the mid-term, and have enhanced our focus on the best growth opportunities ahead," said Blaine Fitzgerald, chief financial officer at Kinaxis. "Financial results in the first quarter were solid, while our ARR continued to reflect caution in the economic environment, particularly among the largest deals where we typically generate most of our growth. Also, for the first time in over a year, ARR growth was notably impacted by foreign exchange fluctuations."

 

Guidance in this press release is provided to enhance visibility into Kinaxis' expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended March 31, 2024 are available on Kinaxis' website and on SEDAR at www.sedar.com .

 

  Changes to the Board
Our long-standing Chair of the board of directors, John (Ian) Giffen, will be leaving the board of directors after Kinaxis' upcoming annual meeting, having served as a director of Kinaxis since 2010. Ian became lead independent director of the board at the time of Kinaxis' IPO in 2014, and Chair in 2018. Our new Chair will be Robert (Bob) Courteau. Ian has guided the board in developing our successful strategy and building shareholder value, including growing our market capitalization by over Cdn$4 billion since Kinaxis' IPO. Ian's achievements in business and governance are renowned in Canada, and most recently he has been recognized as a recipient of the 2024 ICD Fellowship Award. Only 105 directors across Canada have received this recognition over the lifetime of the award. Ian is also widely applauded for his charitable and philanthropic efforts for the Stratford Festival and other organizations. We thank Ian for his countless contributions as Chair.

 

  Conference Call
Kinaxis will host a conference call tomorrow, May 9, 2024, to discuss these results. John Sicard, chief executive officer, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation. Investors and participants must register for the call in advance. See registration link below. Please call the conference telephone number fifteen minutes prior to the start time.

 
            
 

DATE:

 
  

Thursday, May 9, 2024

 
 

TIME:

 
  

8:30 a.m. Eastern Time

 
 

CALL REGISTRATION:

 
  

  https://registrations.events/direct/Q4I9141617384  

 
 

WEBCAST

 
  

  https://events.q4inc.com/attendee/189167848 (available for three months)

 
 

  About Kinaxis Inc.
Kinaxis is a global leader in modern supply chain orchestration. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to orchestrate their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit kinaxis.com or follow us on LinkedIn .

 

  Non-IFRS Measures
This press release makes reference to Adjusted Profit and Adjusted EBITDA, which are non-IFRS financial measures, as well as Adjusted EBITDA margin which expresses Adjusted EBITDA as a percentage of revenue. Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin are not recognized, defined or standardized measures under IFRS. We use these measures to provide investors with supplemental information on our operating performance and to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements, and to determine components of employee compensation.

 

Adjusted Profit represents profit adjusted to exclude the changes in the fair value of contingent consideration, our equity compensation plans and non-recurring items. Adjusted EBITDA represents profit adjusted to exclude the change in the fair value of contingent consideration, our equity compensation plans, non-recurring items, income tax expense, depreciation and amortization, foreign exchange loss (gain) and net finance (income) expense. Adjusted EBITDA margin expresses Adjusted EBITDA as a percentage of revenue. Our definitions of Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin will likely differ from those used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted Profit and Adjusted EBITDA to the most comparable IFRS financial measure as follows:

 
                                                                                                            
 

 

 
 

 

 
 

  Three months ended March 31,  

 
 

 

 
 

 

 
 

  2024  

 
 

 

 
 

 

 
 

  2023  

 
 

 

 
 

 

 
 

(In thousands of USD)

 
 

Profit

 
 

 

 
 

6,187

 
 

 

 
 

 

 
 

 

 
 

1,189

 
 

 

 
 

Change in fair value of contingent consideration

 
 

 

 
 

 
 

 

 
 

 

 
 

 

 
 

2,194

 
 

 

 
 

Share-based compensation

 
 

 

 
 

8,722

 
 

 

 
 

 

 
 

 

 
 

8,219

 
 

 

 
 

Non-recurring item

 
 

 

 
 

1,752

 
 

 

 
 

 

 
 

 

 
 

 
 

 

 
 

Adjusted profit

 
 

 

 
 

16,661

 
 

 

 
 

 

 
 

 

 
 

11,602

 
 

 

 
 

Income tax expense

 
 

 

 
 

2,609

 
 

 

 
 

 

 
 

 

 
 

304

 
 

 

 
 

Depreciation and amortization

 
 

 

 
 

6,405

 
 

 

 
 

 

 
 

 

 
 

6,887

 
 

 

 
 

Foreign exchange gain

 
 

 

 
 

(126

 
 

)

 
 

 

 
 

 

 
 

(265

 
 

)

 
 

Net finance income

 
 

 

 
 

(2,869

 
 

)

 
 

 

 
 

 

 
 

(1,386

 
 

)

 
 

 

 
 

 

 
 

6,019

 
 

 

 
 

 

 
 

 

 
 

5,540

 
 

 

 
 

Adjusted EBITDA

 
 

 

 
 

22,680

 
 

 

 
 

 

 
 

 

 
 

17,142

 
 

 

 
 

Adjusted EBITDA Margin

 
 

 

 
 

19

 
 

%

 
 

 

 
 

 

 
 

17

 
 

%

 
 

  Forward-Looking Statements  

 

  Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to our expectations for:  

 
  •   growth of annual total revenue, annual SaaS and Subscription term licenses revenue, and our expectations for Adjusted EBITDA margin achievement, in each case looking forward for our fiscal year ending December 31, 2024;  
  •  
  •   SaaS growth and increased profitability in years beyond 2024; and  
  •  
  •   contracted revenue in future periods, including 2024, 2025 and 2026 and later.  
  •  

  This release also includes forward-looking statements as to Kinaxis' growth opportunities and the potential benefits of, and markets and demand for, Kinaxis' products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry.  

 

  In particular, our guidance for 2024 annual total revenue, annual SaaS and Subscription term license revenue and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2024, are subject to certain assumptions and associated risks including:  

 
  •   our ability to win business from new customers and expand business from existing customers;  
  •  
  •   the timing of new customer wins and expansion decisions by our existing customers;  
  •  
  •   maintaining our customer retention levels , and specifically, that customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates consistent with our historic experience;  
  •  
  •   fluctuations in the value of foreign currencies relative to the U.S. Dollar; and  
  •  
  •   with respect to Adjusted EBITDA and profitability, our ability to contain expense levels while expanding our business.  
  •  

  Our guidance and commentary for achievement of contracted revenue in future periods, including in 2024, 2025 and 2026 and later, is based on assumptions and associated risks including:  

 
  •   our ability to satisfy material unperformed obligations under our long-term contracts; and  
  •  
  •   the continued financial capacity and creditworthiness of our customers under long-term contracts.  
  •  

  These and other assumptions, risks and uncertainties may cause Kinaxis' actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. Material risks and uncertainties relating to our business are described under the headings "Forward-Looking Statements" and "Risks and Uncertainties" in our annual MD&A dated February 28, 2024, under the heading "Risk Factors" in our Annual Information Form dated March 25, 2024 and in our other public documents filed with Canadian securities regulatory authorities, which are available at    www.sedar   plus.ca    . Forward-looking statements are provided to help readers understand management's expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.  

 

SOURCE: Kinaxis Inc.

 
                                                                                                                                                                                                                            
 

  Kinaxis Inc.  

 

  Condensed Consolidated Interim Statements of Financial Position  

 

(Expressed in thousands of USD)

 

(Unaudited)

 
   
 

 

 
 

March 31,

 

2024

 
 

December 31,

 

2023

 
 

 

 
 

 

 
 

 

 
 

  Assets  

 
 

 

 
 

 

 
 

Current assets:

 
 

 

 
 

 

 
 

Cash and cash equivalents

 
 

$

 
 

219,374

 
 

 

 
 

$

 
 

174,844

 
 

Short-term investments

 
 

 

 
 

83,753

 
 

 

 
 

 

 
 

118,118

 
 

Trade and other receivables

 
 

 

 
 

134,297

 
 

 

 
 

 

 
 

156,609

 
 

Prepaid expenses

 
 

 

 
 

20,654

 
 

 

 
 

 

 
 

14,810

 
 

 

 
 

 

 
 

458,078

 
 

 

 
 

 

 
 

464,381

 
 

Non-current assets:

 
 

 

 
 

 

 
 

Unbilled receivables

 
 

 

 
 

3,933

 
 

 

 
 

 

 
 

3,155

 
 

Other receivables

 
 

 

 
 

917

 
 

 

 
 

 

 
 

972

 
 

Prepaid expenses

 
 

 

 
 

1,020

 
 

 

 
 

 

 
 

1,130

 
 

Investment tax credits recoverable

 
 

 

 
 

9,262

 
 

 

 
 

 

 
 

8,362

 
 

Deferred tax assets

 
 

 

 
 

1,260

 
 

 

 
 

 

 
 

1,184

 
 

Contract acquisition costs

 
 

 

 
 

29,486

 
 

 

 
 

 

 
 

27,438

 
 

Property and equipment

 
 

 

 
 

37,073

 
 

 

 
 

 

 
 

40,300

 
 

Right-of-use assets

 
 

 

 
 

49,921

 
 

 

 
 

 

 
 

47,109

 
 

Intangible assets

 
 

 

 
 

21,761

 
 

 

 
 

 

 
 

23,394

 
 

Goodwill

 
 

 

 
 

73,873

 
 

 

 
 

 

 
 

74,556

 
 

 

 
 

 

 
 

228,506

 
 

 

 
 

 

 
 

227,600

 
 

 

 
 

 

 
 

 

 
 

 

 
 

$

 
 

686,584

 
 

 

 
 

$

 
 

691,981

 
 

 

 
 

 

 
 

 

 
 

  Liabilities and Shareholders' Equity  

 
 

 

 
 

 

 
 

Current liabilities:

 
 

 

 
 

 

 
 

Trade payables and accrued liabilities

 
 

 

 
 

39,086

 
 

 

 
 

 

 
 

39,700

 
 

Deferred revenue

 
 

 

 
 

135,382

 
 

 

 
 

 

 
 

137,598

 
 

Lease obligations

 
 

 

 
 

6,616

 
 

 

 
 

 

 
 

5,805

 
 

 

 
 

 

 
 

181,084

 
 

 

 
 

 

 
 

183,103

 
 

Non-current liabilities:

 
 

 

 
 

 

 
 

Lease obligations

 
 

 

 
 

47,147

 
 

 

 
 

 

 
 

45,985

 
 

Deferred tax liabilities

 
 

 

 
 

7,117

 
 

 

 
 

 

 
 

8,065

 
 

 

 
 

 

 
 

54,264

 
 

 

 
 

 

 
 

54,050

 
 

Shareholders' equity:

 
 

 

 
 

 

 
 

Share capital

 
 

 

 
 

323,260

 
 

 

 
 

 

 
 

307,327

 
 

Contributed surplus

 
 

 

 
 

20,438

 
 

 

 
 

 

 
 

44,339

 
 

Accumulated other comprehensive income (loss)

 
 

 

 
 

(451

 
 

)

 
 

 

 
 

1,360

 
 

Retained earnings

 
 

 

 
 

107,989

 
 

 

 
 

 

 
 

101,802

 
 

 

 
 

 

 
 

451,236

 
 

 

 
 

 

 
 

454,828

 
 

 

 
 

 

 
 

 

 
 

 

 
 

$

 
 

686,584

 
 

 

 
 

$

 
 

691,981

 
 
                                                                                                                                                                                                                         
 

  Kinaxis Inc.  

 

  Condensed Consolidated Interim Statements of Comprehensive Income  

 

(Expressed in thousands of USD, except share and per share data)

 

(Unaudited)

 
  
 

 

 
 

Three months ended March 31,

 
 

 

 
 

2024

 
 

2023

 
 

Revenue

 
 

$

 
 

119,370

 
 

 

 
 

$

 
 

101,130

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Cost of revenue

 
 

 

 
 

46,440

 
 

 

 
 

 

 
 

40,129

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Gross profit

 
 

 

 
 

72,930

 
 

 

 
 

 

 
 

61,001

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Operating expenses:

 
 

 

 
 

 

 
 

Selling and marketing

 
 

 

 
 

24,927

 
 

 

 
 

 

 
 

24,164

 
 

 

 
 

Research and development

 
 

 

 
 

22,985

 
 

 

 
 

 

 
 

19,929

 
 

 

 
 

General and administrative

 
 

 

 
 

19,249

 
 

 

 
 

 

 
 

14,791

 
 

 

 
 

 

 
 

 

 
 

67,161

 
 

 

 
 

 

 
 

58,884

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

5,769

 
 

 

 
 

 

 
 

2,117

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Other income (expense):

 
 

 

 
 

 

 
 

Foreign exchange gain

 
 

 

 
 

126

 
 

 

 
 

 

 
 

265

 
 

 

 
 

Net finance and other income

 
 

 

 
 

2,901

 
 

 

 
 

 

 
 

1,305

 
 

 

 
 

Change in fair value of contingent consideration

 
 

 

 
 

 
 

 

 
 

 

 
 

(2,194

 
 

)

 
 

 

 
 

 

 
 

3,027

 
 

 

 
 

 

 
 

(624

 
 

)

 
 

 

 
 

 

 
 

 

 
 

Profit before income taxes

 
 

 

 
 

8,796

 
 

 

 
 

 

 
 

1,493

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Income tax expense

 
 

 

 
 

2,609

 
 

 

 
 

 

 
 

304

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Profit

 
 

 

 
 

6,187

 
 

 

 
 

 

 
 

1,189

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Other comprehensive income (loss):

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Items that are or may be reclassified subsequently to profit:

 
 

 

 
 

 

 
 

Foreign currency translation differences - foreign operations

 
 

 

 
 

(1,334

 
 

)

 
 

 

 
 

712

 
 

 

 
 

Change in net unrealized loss on cash flow hedges

 
 

 

 
 

(477

 
 

)

 
 

 

 
 

77

 
 

 

 
 

 

 
 

 

 
 

(1,811

 
 

)

 
 

 

 
 

789

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Total comprehensive income

 
 

$

 
 

4,376

 
 

 

 
 

$

 
 

1,978

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Basic earnings per share

 
 

$

 
 

0.22

 
 

 

 
 

$

 
 

0.04

 
 

 

 
 

Weighted average number of basic Common Shares

 
 

 

 
 

28,262,317

 
 

 

 
 

 

 
 

28,086,983

 
 

 

 
 

Diluted earnings per share

 
 

$

 
 

0.21

 
 

 

 
 

$

 
 

0.04

 
 

 

 
 

Weighted average number of diluted Common Shares

 
 

 

 
 

28,953,287

 
 

 

 
 

 

 
 

28,941,335

 
 

 

 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 

  Kinaxis Inc.  

 

  Condensed Consolidated Interim Statements of Changes in Shareholders' Equity  

 

(Expressed in thousands of USD)

 

(Unaudited)

 
    
 

 

 
 

 

 
 

Accumulated other comprehensive income (loss)

 
 

 

 
 

 

 
 

Share

 

capital

 
 

Contributed

 

surplus

 
 

Cash flow

 

hedges

 
 

Currency

 

translation

 

adjustments

 
 

Total

 
 

Retained

 

earnings

 
 

Total equity

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Balance, December 31, 2022

 
 

$

 
 

244,713

 
 

 

 
 

$

 
 

65,129

 
 

 

 
 

$

 
 

 
 

 

 
 

$

 
 

(156

 
 

)

 
 

$

 
 

(156

 
 

)

 
 

$

 
 

91,742

 
 

$

 
 

401,428

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Profit

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

10,060

 
 

 

 
 

10,060

 
 

 

 
 

Other comprehensive income

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

441

 
 

 

 
 

 

 
 

1,075

 
 

 

 
 

 

 
 

1,516

 
 

 

 
 

 

 
 

 
 

 

 
 

1,516

 
 

 

 
 

Total comprehensive income

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

441

 
 

 

 
 

 

 
 

1,075

 
 

 

 
 

 

 
 

1,516

 
 

 

 
 

 

 
 

10,060

 
 

 

 
 

11,576

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Share options exercised

 
 

 

 
 

41,545

 
 

 

 
 

 

 
 

(9,991

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

31,554

 
 

 

 
 

Restricted share units vested

 
 

 

 
 

10,676

 
 

 

 
 

 

 
 

(10,676

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

Performance share units vested

 
 

 

 
 

2,628

 
 

 

 
 

 

 
 

(2,628

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

Share-based payments

 
 

 

 
 

 
 

 

 
 

 

 
 

35,788

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

35,788

 
 

 

 
 

Shares issued for contingent consideration

 
 

 

 
 

11,097

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

11,097

 
 

 

 
 

Shares repurchased

 
 

 

 
 

(3,332

 
 

)

 
 

 

 
 

(33,283

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

(36,615

 
 

)

 
 

Total shareholder transactions

 
 

 

 
 

62,614

 
 

 

 
 

 

 
 

(20,790

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

41,824

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Balance, December 31, 2023

 
 

$

 
 

307,327

 
 

 

 
 

$

 
 

44,339

 
 

 

 
 

$

 
 

441

 
 

 

 
 

$

 
 

919

 
 

 

 
 

$

 
 

1,360

 
 

 

 
 

$

 
 

101,802

 
 

$

 
 

454,828

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Profit

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

6,187

 
 

 

 
 

6,187

 
 

 

 
 

Other comprehensive loss

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

(477

 
 

)

 
 

 

 
 

(1,334

 
 

)

 
 

 

 
 

(1,811

 
 

)

 
 

 

 
 

 
 

 

 
 

(1,811

 
 

)

 
 

Total comprehensive income (loss)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

(477

 
 

)

 
 

 

 
 

(1,334

 
 

)

 
 

 

 
 

(1,811

 
 

)

 
 

 

 
 

6,187

 
 

 

 
 

4,376

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Share options exercised

 
 

 

 
 

5,408

 
 

 

 
 

 

 
 

(1,226

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

4,182

 
 

 

 
 

Restricted share units vested

 
 

 

 
 

6,981

 
 

 

 
 

 

 
 

(6,981

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

Performance share units vested

 
 

 

 
 

5,533

 
 

 

 
 

 

 
 

(5,533

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 
 

 

 
 

Share-based payments

 
 

 

 
 

 
 

 

 
 

 

 
 

9,132

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

9,132

 
 

 

 
 

Shares repurchased

 
 

 

 
 

(1,989

 
 

)

 
 

 

 
 

(19,293

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

(21,282

 
 

)

 
 

Total shareholder transactions

 
 

 

 
 

15,933

 
 

 

 
 

 

 
 

(23,901

 
 

)

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

 
 

 

 
 

(7,968

 
 

)

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Balance, March 31, 2024

 
 

$

 
 

323,260

 
 

 

 
 

$

 
 

20,438

 
 

 

 
 

$

 
 

(36

 
 

)

 
 

$

 
 

(415

 
 

)

 
 

$

 
 

(451

 
 

)

 
 

$

 
 

107,989

 
 

$

 
 

451,236

 
 

 

 
 
                                                                                                                                                                                                                              
 

  Kinaxis Inc.  

 

  Condensed Consolidated Interim Statements of Cash Flows  

 

(Expressed in thousands of USD)

 

(Unaudited)

 
  
 

 

 
 

Three months ended March 31,

 
 

 

 
 

2024

 
 

2023

 
 

 

 
 

 

 
 

 

 
 

Cash flows from operating activities:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Profit

 
 

$

 
 

6,187

 
 

 

 
 

$

 
 

1,189

 
 

 

 
 

Items not affecting cash:

 
 

 

 
 

 

 
 

Depreciation of property and equipment and right-of-use assets

 
 

 

 
 

5,076

 
 

 

 
 

 

 
 

5,475

 
 

 

 
 

Amortization of intangible assets

 
 

 

 
 

1,329

 
 

 

 
 

 

 
 

1,412

 
 

 

 
 

Share-based payments

 
 

 

 
 

8,722

 
 

 

 
 

 

 
 

8,219

 
 

 

 
 

Net finance income

 
 

 

 
 

(2,869

 
 

)

 
 

 

 
 

(1,386

 
 

)

 
 

Change in fair value of contingent consideration

 
 

 

 
 

 
 

 

 
 

 

 
 

2,194

 
 

 

 
 

Income tax expense

 
 

 

 
 

2,609

 
 

 

 
 

 

 
 

304

 
 

 

 
 

Investment tax credits recoverable

 
 

 

 
 

(900

 
 

)

 
 

 

 
 

(915

 
 

)

 
 

Change in operating assets and liabilities

 
 

 

 
 

9,107

 
 

 

 
 

 

 
 

22,959

 
 

 

 
 

Interest received

 
 

 

 
 

4,410

 
 

 

 
 

 

 
 

1,261

 
 

 

 
 

Interest paid

 
 

 

 
 

(382

 
 

)

 
 

 

 
 

(433

 
 

)

 
 

Income taxes paid

 
 

 

 
 

(1,278

 
 

)

 
 

 

 
 

(1,374

 
 

)

 
 

 

 
 

 

 
 

32,011

 
 

 

 
 

 

 
 

38,905

 
 

 

 
 

Cash flows from (used in) investing activities:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Purchase of property and equipment and intangible assets

 
 

 

 
 

(191

 
 

)

 
 

 

 
 

(863

 
 

)

 
 

Purchase of short-term investments

 
 

 

 
 

(59,357

 
 

)

 
 

 

 
 

(55,083

 
 

)

 
 

Redemption of short-term investments

 
 

 

 
 

92,563

 
 

 

 
 

 

 
 

15,006

 
 

 

 
 

 

 
 

 

 
 

33,015

 
 

 

 
 

 

 
 

(40,940

 
 

)

 
 

 

 
 

 

 
 

 

 
 

Cash flows from (used in) financing activities:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Payment of lease obligations

 
 

 

 
 

(1,740

 
 

)

 
 

 

 
 

(1,819

 
 

)

 
 

Repurchase of shares

 
 

 

 
 

(21,282

 
 

)

 
 

 

 
 

 
 

 

 
 

Proceeds from exercise of stock options

 
 

 

 
 

4,182

 
 

 

 
 

 

 
 

10,511

 
 

 

 
 

 

 
 

 

 
 

(18,840

 
 

)

 
 

 

 
 

8,692

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Increase in cash and cash equivalents

 
 

 

 
 

46,186

 
 

 

 
 

 

 
 

6,657

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Cash and cash equivalents, beginning of period

 
 

 

 
 

174,844

 
 

 

 
 

 

 
 

175,347

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Effects of exchange rates on cash and cash equivalents

 
 

 

 
 

(1,656

 
 

)

 
 

 

 
 

(438

 
 

)

 
 

 

 
 

 

 
 

 

 
 

Cash and cash equivalents, end of period

 
 

$

 
 

219,374

 
 

 

 
 

$

 
 

181,566

 
 

 

 
 

 

 

  

  

  Investor Relations  
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com  
613-907-7613

 

  Media Relations  
Jaime Cook | Kinaxis
jcook@kinaxis.com  
289-552-4640

 

News Provided by Business Wire via QuoteMedia

KXS:CA
The Conversation (0)
Kinaxis Announces Results of Voting at Annual Meeting of Shareholders

Kinaxis Announces Results of Voting at Annual Meeting of Shareholders

 

  Kinaxis® Inc. ("Kinaxis" or the "Company") (TSX:KXS), a leading provider of supply chain orchestration solutions, received approval for all resolutions put forward to shareholders at today's Annual Meeting of Shareholders (the "Meeting"), as detailed in the Company's management information circular dated April 18, 2024 (the "Circular").

 

  1. Election of Directors   

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Micro Logic to Help Kinaxis Accelerate AI Innovation Efforts for Supply Chain

Micro Logic to Help Kinaxis Accelerate AI Innovation Efforts for Supply Chain

 
 

  Supply chain leader gains access to NVIDIA DGX platform, the world's most advanced AI system  

 

Micro Logic the leading sovereign cloud provider in Canada today announced it has been selected by Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, to help accelerate the company's product innovation pipeline.

 

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Kinaxis Selected as Supply Chain Orchestration Solution by Intercos Group

Kinaxis Selected as Supply Chain Orchestration Solution by Intercos Group

 

  World-leading Italian cosmetic company to gain full transparency across its global supply chain  

 

  Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Intercos Group , one of the leading cosmetics contract manufacturers, has selected Kinaxis to provide full visibility and transparency across its supply chain.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches

Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches

 

  Kinaxis to drive supply chain efficiencies for Servier's targeted portfolio of lifesaving drugs  

 

  Kinaxis ® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced that Servier , a global independent pharmaceutical group, has selected Kinaxis to help revolutionize its supply chain planning capabilities with a view to accelerating time to market for its portfolio of life-saving drugs.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Kinaxis Announces Flo Rida as Music Headliner for Kinexions 2024

Kinaxis Announces Flo Rida as Music Headliner for Kinexions 2024

 

  Hip-hop hitmaker will take the stage at the premier supply chain conference of the year  

 

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that multi-platinum hip-hop artist Flo Rida will take center stage at Kinexions, the company's annual community conference taking place June 17 20, 2024 in Miami.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×